Australia markets open in 6 hours 2 minutes

Enwei Pharmaceutical Co., Ltd. (301331.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
21.87-0.16 (-0.73%)
At close: 03:04PM CST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
67,067
86,312
67,801
101,735
98,743
-
Depreciation & amortisation
-
34,830
30,907
30,497
32,785
-
Change in working capital
-
-40,903
-42,731
-50,233
-63,640
-
Inventory
-
-2,901
5,404
-31,394
-7,478
-
Other working capital
-60,537
-50,038
38,796
49,363
47,357
-
Other non-cash items
-
16.4882
5,318
5,070
4,295
-
Net cash provided by operating activities
-
84,011
62,354
87,577
78,521
-
Cash flows from investing activities
Investments in property, plant and equipment
-150,109
-134,049
-23,558
-38,214
-31,164
-
Purchases of investments
-
-
-
-
-
-818.2
Sales/maturities of investments
-
3,662
-
-
-
-
Other investing activities
66,203
86,061
-220,449
518.3091
322.1323
-
Net cash used for investing activities
-79,290
-44,176
-244,008
-37,695
-30,831
-
Net change in cash
-143,086
-105,414
276,981
1,231
15,604
-
Cash at beginning of period
363,773
341,231
64,250
63,019
47,415
-
Cash at end of period
220,689
235,817
341,231
64,250
63,019
-
Free cash flow
Operating cash flow
-
84,011
62,354
87,577
78,521
-
Capital expenditure
-150,109
-134,049
-23,558
-38,214
-31,164
-
Free cash flow
-60,537
-50,038
38,796
49,363
47,357
-